The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-(5-(3,5-dimethylisoxazol-4-yl)-3-(4-fluorobenzyl)-1H-indol-1-yl)-N-hydroxyoctanamide ID: ALA5277234
Max Phase: Preclinical
Molecular Formula: C28H32FN3O3
Molecular Weight: 477.58
Associated Items:
Names and Identifiers Canonical SMILES: Cc1noc(C)c1-c1ccc2c(c1)c(Cc1ccc(F)cc1)cn2CCCCCCCC(=O)NO
Standard InChI: InChI=1S/C28H32FN3O3/c1-19-28(20(2)35-31-19)22-11-14-26-25(17-22)23(16-21-9-12-24(29)13-10-21)18-32(26)15-7-5-3-4-6-8-27(33)30-34/h9-14,17-18,34H,3-8,15-16H2,1-2H3,(H,30,33)
Standard InChI Key: VKSHXRYAERJOBI-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
-2.5973 1.9208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5973 1.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8840 0.6894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1768 1.0995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1768 1.9212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8857 2.3314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3953 2.1751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0876 1.5103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3953 0.8455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1826 0.0518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6110 -0.1608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8237 -0.9546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6175 -1.1673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8302 -1.9611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6240 -2.1738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8366 -2.9675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6304 -3.1802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8431 -3.9739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6368 -4.1866 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2114 -2.5991 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1826 2.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6111 3.1816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8240 3.9753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6156 4.1866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1968 3.6054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9867 2.8151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1947 2.5980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9906 3.8181 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.3090 2.3317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4868 3.1293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3075 3.2213 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6368 2.4898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0207 1.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0207 1.0991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9057 3.7104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
5 7 1 0
7 8 2 0
8 9 1 0
4 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
17 20 2 0
7 21 1 0
21 22 1 0
23 22 2 0
24 23 1 0
25 24 2 0
26 25 1 0
27 26 2 0
22 27 1 0
25 28 1 0
29 1 1 0
29 30 2 0
30 31 1 0
32 31 1 0
33 32 2 0
29 33 1 0
33 34 1 0
30 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 477.58Molecular Weight (Monoisotopic): 477.2428AlogP: 6.49#Rotatable Bonds: 11Polar Surface Area: 80.29Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 8.91CX Basic pKa: 1.42CX LogP: 5.84CX LogD: 5.83Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.15Np Likeness Score: -1.01
References 1. Han Y, Dong W, Guo Q, Li X, Huang L.. (2020) The importance of indole and azaindole scaffold in the development of antitumor agents., 203 [PMID:32688198 ] [10.1016/j.ejmech.2020.112506 ]